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Note from the Editors: Instructions for reviewers of study protocols
Since launching in 2011, BMJ Open has published study protocols for planned or ongoing research 
studies. If data collection is complete, we will not consider the manuscript.
Publishing study protocols enables researchers and funding bodies to stay up to date in their fields 
by providing exposure to research activity that may not otherwise be widely publicised. This can help 
prevent unnecessary duplication of work and will hopefully enable collaboration. Publishing 
protocols in full also makes available more information than is currently required by trial registries 
and increases transparency, making it easier for others (editors, reviewers and readers) to see and 
understand any deviations from the protocol that occur during the conduct of the study.
The scientific integrity and the credibility of the study data depend substantially on the study design 
and methodology, which is why the study protocol requires a thorough peer-review. 
BMJ Open will consider for publication protocols for any study design, including observational 
studies and systematic reviews.
Some things to keep in mind when reviewing the study protocol: 
 Protocol papers should report planned or ongoing studies. The dates of the study should be 
included in the manuscript. 
 Unfortunately we are unable to customize the reviewer report form for study protocols. As 
such, some of the items (i.e., those pertaining to results) on the form should be scored as 
Not Applicable (N/A).
 While some baseline data can be presented, there should be no results or conclusions 
present in the study protocol. 
 For studies that are ongoing, it is generally the case that very few changes can be made to 
the methodology. As such, requests for revisions are generally clarifications for the rationale 
or details relating to the methods. If there is a major flaw in the study that would prevent a 
sound interpretation of the data, we would expect the study protocol to be rejected. 
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ABSTRACT
Introduction
The potential for digital medicine and health care in geriatric oncology settings has received 
much attention. This scoping review will summarise the nature and extent of the existing 
literature that describes and examines digital health development, implementation, evaluation, 
outcome and experience for older adults with cancer, their families and their health care 
providers.
Methods and Analysis
Arksey and O'Malley’s six stages of scoping review methodology framework will be used. 
Searches will be conducted in Cochrane Central Register of Controlled Trials (CENTRAL), 
PubMed, Embase via OvidSP, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) Plus via EBSCO, Scopus, and PsycINFO via OvidSP for published articles in peer-
reviewed scientific journals from year 2000 onwards. In addition, we will screen databases for 
all prospectively registered trials. Research articles using quantitative or qualitative study 
design or reviews will be included if they describe or report the design, development, or 
usability of digital health interventions in the treatment and care of patients 65 years of age or 
older with cancer and their families before, during and after cancer treatment. Grey literature 
will not be searched and included. Two investigators will independently perform the literature 
search, eligibility assessments and study selection. A Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses flow diagram for the scoping reviews (PRISMA-ScR) will be 
used to delineate the search decision process. For included articles, the extracted results will 
be synthesised both quantitatively and qualitatively and reported under key conceptual 
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categories of this scoping review. Research gaps and opportunities will be identified and 
summarised.
Ethics and Dissemination
Since this review will only include published data, ethics approval will not be sought. The 
results of the review will be published in peer-reviewed scientific journals. We will also engage 
with relevant stakeholders within research team’s networks to determine suitable approaches 
for dissemination.
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Strengths and Limitations of this Study
 This review will use an established, rigorous and systematic framework for conducting 
scoping reviews to explore in detail the current state of knowledge and evidence about 
digital health for older adults with cancer and their families.
 Gaining insights into the characteristics and contexts leading to positive outcomes, 
patient/family and healthcare provider experience, and integration challenges and 
barriers will provide a big picture on digital health progress in geriatric oncology 
settings and would be helpful in identifying what recommendations can be made to 
improve gaps in the research and knowledge base.
 This scoping review will not examine health economic and clinical utility evidence for 
digital health.
 We will not assess the risk of bias and the quality of evidence of included studies as the 
goals are to identify and summarise research gaps and opportunities.
 Given the anticipated volume of peer-reviewed scientific literature and databases for 
prospectively registered trials, grey literature will not be searched and included.
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Introduction
More than 60% of all cancers arise in the older adult population.1 It is estimated by 2030, 
people 65 years of age or older will account for 70% of cancer diagnoses.2 Coupled with an 
increased incidence of cancer among older people is the unprecedented demographic growth 
of the elderly population. The United Nations highlighted that populations are becoming older 
in all regions of the world, with an estimate that one in six people globally will be 65 years or 
older by 2050.3 Such epidemiological evidence highlights the importance of advancing the 
knowledge base in geriatric-oncology settings and improving clinical management. Older 
people make up a unique group of patients in a clinical cancer setting and are at increased risk 
for toxic side effects during cancer treatment.4,5 Treatment of older patients is complicated by 
the fact that many are entering the cancer trajectory with pre-existing co-morbidities and 
susceptibility to the progressive accumulation of multiple chronic diseases and a decline in 
functional capabilities.6-9 The assessment, treatment and supportive care needs of older patients 
with cancer are substantial and complex. 
Geriatric oncology has progressed immensely in terms of understanding the predicative ability 
of baseline comprehensive geriatric assessment for chemotherapy toxicity and treatment 
completion.8,10 However, concerns remain about how to improve the experience of older cancer 
patients11,12 and their tolerance of and adherence to cancer treatment regimens to optimise the 
full benefits of chemotherapy.12 Chouliara et al. indicated that symptom management, 
chemotherapy, choices of medical provider, complementary treatments and family 
involvement in the patient’s care are important decision-making topics for older people with 
cancer and their relatives.13 There is a pressing need to open new avenues for effective 
treatment, care and support of older patients with cancer to optimise clinical and patient 
outcomes.
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The growth and advancement of digital technology through the integration of sensor arrays, 
interactive multi-touch screens, voice and video media, interactive longitudinal data, the 
advanced functions of apps, high computing power and fast network speed have revolutionised 
the medical and health care sciences. Shen and Naeim highlighted that digital technology has 
transformed the ways that healthcare can be delivered all across the world.14 Literature 
resources are rapidly expanding to include digital health applications and evaluations, 
technology integration into health care systems, technology literacy and exposure, and 
technology acceptance, barriers and engagement across a wide spectrum of health care 
domains.15-17 These insights are helpful for the geriatric oncology field. 
Technology use by older adults is increasing, and the potential for digital medicine and health 
care in oncology settings has received much attention. In 2016, the adoption rates of 
smartphones and tablets by older adults 60 to 69 years of age were 46% and 41%, 
respectively.18 Perrin and Duggan indicated that 60% of individuals older than 65 years have 
internet access and go online.19 Recent reviews identified the potential of, and need for, both 
remote digital self-reporting solutions for cancer and treatment-related symptoms using Web 
or smart phone-based portals, and Internet of Things–based solutions using various ambient-
sensing technologies to enable objective and real-time monitoring of treatment toxicity, 
symptoms and functional status in geriatric oncology settings.14,20 Denis et al. demonstrated 
that remote symptom monitoring using a Web-based self-report of symptoms improved overall 
survival rates among lung cancer patients 35.7 to 88.1 years of age (median age, 64.5 years).21 
The functional performance status of older cancer patients has also been monitored with 
wearable electronic activity monitoring technologies.22 Villani et al. evaluated e-health stress 
inoculation training intervention on emotional regulation and cancer-related well-being in 29 
women over 55 years of age with breast cancer (mean age, 62.76 years), and revealed a good 
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level of acceptance of the ehealth intervention, an increase in relaxation and a reduction in 
anxiety among women in the intervention group.23 Hoogland et al. surveyed eHealth literacy 
in older adults with cancer and found that older adults had significantly lower eHealth literacy 
than younger patients, which suggests older cancer patients’ needs and abilities should be 
considered when designing and implementing health information technology.17 
There is a need for comprehensive evidence to inform the research and development of digital 
health solutions, and t  understand the imperatives of designing, implementing and evaluating 
digital health care initiatives in the context of geriatric oncology populations. Peters et al noted 
that a scoping review is particularly useful when a body of literature has not been 
comprehensively reviewed.23 Scoping reviews are one of the most common forms of review in 
healthcare sciences, and are characterized as a broader approach with the aim of mapping 
literature and addressing a broader research question.23 An appealing feature of scoping review 
methodology, contrary to other review approaches, is that it does not limit the parameters of 
the review to randomised controlled trials or require methodological homogeneity of studies 
included in a review.25 Such an approach is consistent with literature that the hierarchies of 
evidence used in existing health research should be replaced by embracing diverse research 
methods approaches.26 Indeed, the inclusion of published literature in a particular field as a 
whole regardless of its methodological approaches, settings and contexts is necessary to 
provide a big picture of existing knowledge, thereby improving research planning, strategic 
research prioritization and evidence-informed policies.27 Literature also indicates that scoping 
reviews are rigorous in their approach to providing rich and contextual details evidence of 
research activity in a particular area.28 Despite the strengths, the lack of methodological quality 
assessment and quality of evidence grading even for empirical evidence minimises the ability 
of results from a scoping review to inform clinical decision making. A recent critical review of 
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the scoping review methods indicated that results of scoping reviews are not used to create 
recommendations for policy or practice.28 Other important challenges in scoping reviews are 
the level of complexity across multiple stages28 and practical issues related to the large corpus 
and the wide range of research literature.25 Therefore, it is crucial to follow a sound 
methodological guidance or framework,28 and to have a balance between breadth, 
comprehensiveness and feasibility.29 Consistent with the rationale for conducting scoping 
reviews, the scoping review methodology of knowledge synthesis is well suited to the present 
review study purpose. Here we describe a scoping review protocol to systematically review 
published literature on digital health for older adults with cancer, their families and their health 
care providers. 
The purpose of this scoping review protocol is to systematically map and explore the literature 
and evidence describing and examining digital health development, implementation, 
evaluation, outcome and experience for older adults with cancer, their families and their health 
care providers. We focus primarily on evaluation of baseline performance status and/or 
geriatric assessment, clinical assessment, treatment outcomes, and patient management 
including self-management and self-monitoring. The following points in the cancer pathway 
are considered: before, during and after cancer treatment, which includes surgery, adjuvant 
chemotherapy and/or radiotherapy, targeted therapy, follow-up care during remission and 
survivorship care. Our goals are to direct future research efforts by identifying gaps and 
limitations in the literature and to highlight relevant determinants of positive outcomes in the 
emerging field of geriatric oncology.
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Methods
Our protocol was developed using the scoping review methodological framework proposed by 
Arksey and O'Malley30 and further refined by the Joanna Briggs Institute.24 The approach 
describes six methodological stages: (1) identification of the research question, (2) 
identification of relevant studies, (3) selection of studies, (4) extracting and charting the results, 
(5) collating, summarising and reporting the results, and (6) consultation with stakeholders 
(optional).
Identifying the research questions (Stage 1)
This scoping review will answer the following questions:
 To what extent digital health has been established or utilised in the field of geriatric 
oncology?
 What scientific evidence exists for the effectiveness of various types of digital health 
interventions for older cancer patients and their families?
 Which participant and digital health intervention characteristics, and context are 
associated with positive outcomes?
 What are the experiences of older cancer patients, their families and their health care 
providers of digital health care?
 What are challenges and barriers of integrating digital health into clinical practice?
Identification of relevant studies (Stage 2)
Search strategy
The team collaborated to plan a search strategy in consultation with a medical librarian to 
identify a comprehensive list of relevant literature specific to digital health for older adults with 
cancer and their families. The electronic search for literature will focus on retrieving published 
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articles in peer-reviewed scientific journals by a systematic search of the following databases: 
Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase via OvidSP, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus via EBSCO, Scopus, 
and PsycINFO via OvidSP.
We will retrieve all journal articles published in the English language from year 2000 onwards 
(1 Jan 2000 to 25 May 2020) to accommodate the emergence of the geriatric oncology as a 
field with the formation of International Society of Geriatric Oncology in 2000,31 hence 
research in this field only became mainstream and gained momentum after 2000. In addition, 
the publishing date range (within the last 20 years) will accommodate the wide adoption of 
digital health care following publication of WHO vision for digital health32 and after the 
introduction of smartphones. Two investigators will independently perform the literature 
search, eligibility assessments and study selection. We performed a pilot search on PubMed to 
identify relevant keywords contained in the title, abstract and subject descriptors. We will use 
the following search terms related to digital health and older adults with cancer, with various 
combinations in each electronic database while using controlled vocabulary with the Boolean 
operators AND and OR. We will use appropriate subject headings (e.g., MeSH headings) 
whenever possible. The term ‘health care providers’ encompasses oncologists, nurses, nurse 
practitioners, clinicians, physicians, general practitioners and pharmacists in this scoping 
review. A copy of the search strategies and the preliminary searches results in each electronic 
database is included as an online supplementary file.
The basic search terms used will be:
1. (Older adult* OR Older person OR Elderly OR Geriatric) AND (Neoplasm* OR Cancer 
OR Carcinoma) 
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2. (Famil* OR Carer* OR Caregiver* OR Health care provider* OR Healthcare 
professional* OR Nurs* OR Oncolog* OR General practitioner OR Practitioner OR 
Nurse practitioner OR Pharmacy OR Clinician OR Physician)
3. (Internet OR Telemonitor* OR Teleconsultat* OR Telehealth OR Telecare OR 
Website* OR App OR Apps OR Application* OR Digital OR eHealth OR mHealth) 
4. (1 AND 2) AND 3
We will also screen reference lists of all identified studies and reviews for any relevant 
publications. Finally, we will screen databases for ongoing clinical trials and all prospectively 
registered trials, including the WHO ICTRP and ClinicalTrials.gov.
Selection of studies (Stage 3)
Studies will be selected following two stages of screening. The first stage will be an initial 
screening of titles and abstracts by two reviewers independently to assess relevance. The initial 
review will be done independently, and the reviewers will discuss the results once screening is 
complete. Resolving disagreements will be attempted first by the two reviewers, but if 
necessary, a third member of the research team will be consulted to reach consensus. Once the 
initial decision is reached on which articles to include, we will begin the second stage of 
conducting a full-text review. Two reviewers will independently assess the articles to determine 
whether they meet the inclusion criteria. Disagreements regarding inclusion will be discussed 
and resolved by consensus, with a third member of the research team adjudicating articles 
without a consensus agreement or with questions about their relevance or eligibility. The first 
stage of screening is underway.
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Table 1 delineates the inclusion and exclusion criteria, following the Population, Concept and 
Context (PCC) categories for scoping reviews.24 We will iteratively refine the inclusion and 
exclusion criteria to align potentially eligible studies to the purpose of this scoping review.24 
Inclusion criteria are studies that focus on: (1) older individuals 65 years of age or older (or 
where the mean or median age of the study sample was 65 years of age or older) who had any 
cancer diagnosis, and/or family members including carers of older adults with cancer, and/or 
health  care providers; (2a) describing or reporting the design, development, or usability of 
digital health interventions in the treatment and care of older patients with cancer and their 
families before, during and after cancer treatment; (2b) evaluating the effectiveness of various 
types of digital health interventions for older cancer patients and their families, and the 
characteristics and contexts contributing to positive clinical and patient outcomes or 
experiences; (2c) reporting the challenges and barriers of integrating digital health into clinical 
practice in a geriatric oncology setting; (3) how geriatric oncology treatment, services and care 
are provided in clinical and community settings. The inclusion of both clinical and community 
settings is meant to provide a comprehensive picture of the digital health landscape in geriatric 
oncology settings, particularly gaining insights into the interface between clinical 
treatment/care in hospital and remote monitoring of treatment toxicity, symptoms and 
functional status in community. Research articles using quantitative or qualitative study design 
or reviews will be included to support the greater breadth of this scoping review.24 Peer-
reviewed scientific articles describing study protocols will also be included. 
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for the 
scoping reviews (PRISMA-ScR) will be used to delineate the search decision process for the 
scoping review.33 This will include the results from the search, removal of duplicate citations, 
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study selection, full retrieval, and additions from reference list searching and final selection for 
inclusion in the scoping review.
INSERT TABLE 1 HERE
Extracting and charting the results (Stage 4)
In this stage, articles that meet the criteria for inclusion will be summarized. Literature 
highlighted that the essence of data extraction is to record characteristics of the included studies 
and key information relevant to the review questions.24  Congruent with the purpose and 
questions of this scoping review and taking reference from the existing digital health 
interventions design and evaluation framework,34 we identified a priori categories and related 
variables including ‘general information categories’, ‘key conceptual categories’, and 
‘additional categories’ with related variables described below as the data extraction framework 
to guide the extraction and charting of data from the included studies. A data chart will be 
developed based on the data extraction framework by our research team. The general 
information and the key quantitative and/or qualitative findings of the included studies will be 
extracted into the data chart. The data chart will be piloted by two reviewers on two or three 
studies, and differences in charting will be resolved by a third member of the research team. 
After the pilot trial, the results will be discussed with the research team to determine whether 
the data chart satisfactorily captures the information to align and be consistent with the purpose 
and questions of this scoping review.35 Refinements will be made after the pilot trial if deemed 
necessary by the research team. In addition, the data extraction framework will be updated or 
refined according to categories and related variables emerging as the conduct of the review 
progresses.24 Any iterative changes or refinements needed during the actual conduct of the full 
review will be clearly detailed and explained in the future scoping review report paper(s).
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General information categories
General information that will be included in this chart include: description of study 
characteristics (e.g., year of publication, country of origin, the geographical location in which 
the research was conducted, aims/purpose, methodology and sample size); descriptions of 
study populations (e.g., age, gender, residence, ethnicity, cultural background, socioeconomic 
status, functionality, cognition, disability, comorbidity and family carers); type and stage of 
cancer, and years of survival after cancer diagnosis; milestones along the cancer continuum 
(e.g., before, during and after cancer treatment including follow-up care during remission and 
survivorship care); cancer treatment (e.g., surgery, chemotherapy, radiation and/or targeted 
therapy); context of cancer treatment and care (e.g., clinical and community); and survival from 
diagnosis. For studies in which digital health interventions are developed, the theoretical basis 
underpinning the intervention, and the extent to which stakeholders including patients, family 
and health care providers were involved in the development of the intervention will be 
extracted when possible. For studies that evaluate digital health interventions, the digital health 
intervention type according to WHO classification36 and comparator, mode of delivery, study 
design, outcome measures and context, and key findings that relate to the scoping review 
questions will be extracted. 
Key conceptual categories
An initial set of data extraction variables that correspond with the key conceptual categories of 
this scoping review will be extracted, including the development (e.g., conceptual and 
technological foundation; intervention component and content), usability (e.g., usage rate), 
effectiveness (e.g., process, impact and outcome), context (e.g., personal and environment 
context) and experiences of digital health interventions (e.g., positive, neutral and negative 
experience); and the challenges and barriers (e.g., individual characteristics, social support, 
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workforce, planning, funding for equipment, cost of technology, guidelines, methodology, and 
ways and timing in which digital health could be integrated/adapted) of integrating digital 
health into clinical practice. Additionally, methodological and knowledge gaps in the research 
and future research directions offered by author(s) will be extracted from the included studies. 
This information will also be noted for studies whose study population was not older adults 
with cancer, but rather families or health care providers.
Additional categories
We drew on digital health intervention design and evaluation framework34 to identify the 
following sets of variables which will be extracted from the included studies to strengthen the 
technological foundation of evidence: eHealth literacy, ease of use, perceived benefit, content 
quality, personalization, adherence, safety, privacy and security.
Collating, summarising and reporting the results (Stage 5)
Describing and reporting the study characteristics 
The extracted data will be summarised to provide a description of the collected data. 
Descriptive statistics including frequencies and central measures of tendency will be used to 
report the number of studies under each general information, key conceptual and additional 
category, such as the type of study design, the type of digital health intervention, the outcomes 
or experiences of digital health care at each stage of the cancer continuum, the type of 
contributing characteristics, and the type of challenges and barriers. Descriptive statistics and 
numerical summaries will be reported in tables and/or in narrative form. 
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Synthesising and reporting qualitative and quantitative evidence
The extracted results will be synthesised and reported under key conceptual categories aligning 
to the purpose and questions of this scoping review including: the development, usability, 
outcomes, effectiveness, context and experiences of digital health interventions; and the 
challenges and barriers of integrating digital health into clinical practice. In accordance with 
recommendations from the literature,37 a parallel-results convergent synthesis design will be 
used to synthesise quantitative and qualitative data, where both types of evidence will be 
analysed and presented separately, with integration occurring during the interpretation of 
results.37 A particular strength of the parallel-results convergent design is that it provides a 
synthesis strategy for addressing multiple complementary review questions pertaining to our 
broadly covered topic with regards to digital health for older adults with cancer and their 
families, thereby providing a big picture of existing knowledge, evidence and research gaps. 
For quantitative data, we will use frequency distribution analysis to describe the data and map 
out the evidence by providing a summary of the counts of the included studies.29 We will also 
use thematic synthesis to contextualise the findings of the quantitative studies where 
appropriate. For qualitative data, a narrative synthesis of the findings will be conducted for 
review questions pertaining to development, usability, outcomes and effectiveness.37 Major 
review findings will be summarized and explained. In addition, thematic synthesis will be used 
to synthesise data from qualitative studies that address the review questions related to context 
and people’s views and experiences. Major themes will be identified and developed across 
included studies.37 Research gaps and opportunities will also be identified and summarised. 
The review results may be presented as a ‘numerical summary’, ‘narrative summary’, ‘table’, 
‘conceptual map’ and/or ‘schematic representation’ of the data. We may decide on additional 
presentation formats after data extraction from the included studies, so to make sure results 
data are clear and visually compelling to the readers.28
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Consultation with stakeholders (Stage 6)
We will engage with relevant stakeholders within the research team’s networks, including 
oncology/geriatric oncology health care providers, regional and international community and 
professional organisations, and digital health developers, if it is feasible for them to contribute 
towards the interpretation as well as research and policy implications of the results, so as to 
improve the relevance and impact of this scoping review. In addition, we aim to engage with 
stakeholders to determine suitable approaches for dissemination and additional knowledge 
translation initiatives, so as to optimise knowledge translation. 
Patient and public involvement
Patient and public involvement strategy or group was not used in the development of this 
scoping review protocol. Neither patients nor the public were involved in the design and the 
development of the protocol. Nevertheless, we might invite older adults with cancer and their 
families from patient support groups within research team’s networks at the consultation phase 
to determine suitable approaches for dissemination of review findings.
Ethics and dissemination 
This scoping review protocol outlines a method to rigorously and systematically search and 
map the literature on digital health for older adults with cancer and their families. Since this 
review will only include published data, ethics approval will not be sought. Results from this 
review will be disseminated through peer-reviewed scientific journals and major professional 
conferences. We will also engage with relevant stakeholders within research team’s networks 
to determine suitable approaches for dissemination after the completion of stage five of the 
review methodology. We anticipate that our review results regarding the current state of 
knowledge and evidence about digital health in geriatric oncology could provide direction for 
future research efforts and inform clinical practice and policy. Congruent with the scoping 
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review methodology guidance, we will consider the implications of review results within the 
broader context.25
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Table 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Population:
Older adults with cancer, their 
families, oncology health care 
providers
Older individuals 65 years of 
age or older (or where the 
average age of the study 
sample was 65 years of age or 
older) who had any cancer 
diagnosis.
Family members including 
carers of older adults with 
cancer, and/or oncology health 
care providers.
Studies on digital health 
interventions of adults with 
cancer where 65 years of age 
or older were not reported 
separately.
Concept or Focus:
Development, usability, 
outcomes, effectiveness, 
context and experiences of 
digital health interventions; 
and challenges and barriers of 
integrating digital health into 
clinical practice
Studies describing or reporting 
the design, development, or 
usability of digital health 
interventions (teleconsultation, 
telemedicine, telehealth, 
telecare, telemonitoring, 
geriatric and oncology care 
programmes, patient platforms, 
self-care websites, informative 
websites, and mobile apps) in 
the treatment and care of older 
patients with cancer and their 
families before, during and 
after cancer treatment (surgery, 
adjuvant chemotherapy and/or 
radiotherapy, targeted therapy) 
including follow-up care 
during remission and 
survivorship care .
Studies evaluating the 
effectiveness of various types 
of digital health interventions 
for older cancer patients and 
their families, and the 
characteristics and contexts 
contributing to positive clinical 
and patient outcomes or 
experiences. 
Studies reporting the 
challenges and barriers of 
integrating digital health into 
clinical practice in a geriatric 
oncology setting.
Studies validating electronic 
versions of scales or 
questionnaire forms of existing 
instruments or electronic 
patient records.
Studies reporting costs of the 
digital health interventions 
only.
Studies on digital health 
interventions being used for
diagnostics/imaging
Context:
Provision of geriatric oncology 
treatment including surgery, 
Studies conducted in clinical 
and/or community (including 
home) settings.
Studies conducted in screening 
and diagnostic settings.
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adjuvant chemotherapy and/or 
radiotherapy, targeted therapy), 
services and care in clinical 
and/or community settings
Others English 
Articles published after 2000
Original or review research 
articles 
Qualitative (qualitative 
descriptive, phenomenological, 
ethnographical, grounded 
theory, realistic evaluation, 
action research, etc.), 
quantitative (random controlled 
trials, cohort study, case–
control and cross-sectional, 
etc.) or reviews (systematic 
review, meta-analysis, scoping 
review, narrative review, etc.) 
or descriptions of study 
protocols
Editorials
Opinion/perspective papers
Conference abstracts
Case reports
Theses/dissertations.
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Protocol for a scoping review of digital health for older adults with cancer and their 
families (supplementary file)
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3KANESVARAN Ravindran, 2ARMES Jo
1Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore 
2School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford, United Kingdom
3National Cancer Centre Singapore, Singapore
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Supplementary File – Search Strategies and Preliminary Search Results in Each Electronic 
Database 
Search Strategies
The basic search on Key terms via Pubmed and Cochrane will be:
1. (Older adult*[Title/Abstract] OR Older person[Title/Abstract] OR Elderly[Title/Abstract] OR 
Geriatric[Title/Abstract]) AND (Neoplasm*[Title/Abstract] OR Cancer[Title/Abstract] OR 
Carcinoma[Title/Abstract]) 
2. (Famil*[Title/Abstract] OR Health care provider*[Title/Abstract] OR Healthcare 
professional*[Title/Abstract] OR Carer*[Title/Abstract] OR Caregiver*[Title/Abstrac OR 
Oncolog*[Title/Abstract])t] OR Nurs*[Title/Abstract] OR General 
practitioner[Title/Abstract]) OR Practitioner[Title/Abstract]) OR Nurse 
practitioner[Title/Abstract]) OR Pharmacy[Title/Abstract]) OR Clinician[Title/Abstract]) OR 
Physician[Title/Abstract])
3. (Internet[Title/Abstract] OR Telemonitor*[Title/Abstract] OR Teleconsultat*[Title/Abstract] 
OR Telehealth[Title/Abstract] OR Telecare[Title/Abstract] OR Website*[Title/Abstract] OR 
App[Title/Abstract] OR Apps[Title/Abstract] OR Application*[Title/Abstract] OR 
Digital[Title/Abstract] OR eHealth[Title/Abstract] OR mHealth[Title/Abstract])
4. (1 AND 2) AND 3
The basic search on MeSH terms via Pubmed and Cochrane will be:
1. (Aged[Mesh]) AND (Neoplasms[Mesh] OR Carcinoma[Mesh])
2. (Family[Mesh] OR Caregivers[Mesh] OR Health Personnel[Mesh] OR Nursing[Mesh] OR 
Nurses [Mesh] OR Oncology nursing[Mesh] OR General practitioners[Mesh] OR Nurse 
practitioners[Mesh] OR Family Nurse Practitioners[Mesh] OR Pharmacy[Mesh] OR 
Physicians[Mesh])
3. (Telemedicine[Mesh] OR Telecommunications[Mesh] OR Patient portals[Mesh] OR Mobile 
applications[Mesh] OR Internet-based intervention[Mesh])
4. (1 AND 2) AND 3
The basic search on Key terms via EMBASE will be:
1. (Older adult*:ti,ab OR Older person:ti,ab OR Elderly:ti,ab OR Geriatric:ti,ab) AND  
(Neoplasm*:ti,ab OR Cancer:ti,ab OR Carcinoma:ti,ab)
2. (Famil*:ti,ab OR Health care provider*:ti,ab OR Healthcare professional*:ti,ab OR 
Carer*:ti,ab OR Caregiver*:ti,ab OR Nurs*:ti,ab OR Oncolog*:ti,ab OR General 
practitioner:ti,ab OR Practitioner:ti,ab OR Nurse practitioner:ti,ab OR Pharmacy:ti,ab OR 
Clinician:ti,ab OR Physician:ti,ab)
3. (Internet:ti,ab OR Telemonitor*:ti,ab OR Teleconsultat*:ti,ab OR Telehealth:ti,ab OR 
Telecare:ti,ab OR Website*:ti,ab OR App:ti,ab OR Apps:ti,ab OR application*:ti,ab OR 
Digital/exp OR 'eHeallth'/exp OR 'mHealth'/exp)
4. (1 AND 2) AND 3
The basic search on Emtree terms via EMBASE will be:
1. (Aged/exp OR Geriatric patient/exp) AND (Neoplasm/exp OR Cancer/exp OR Carcinoma/exp)
2. (Family/exp OR Health care personnel/exp OR Health Personnel/exp OR Nursing/exp OR 
Oncology/exp OR Nursing/exp OR General practitioner/exp OR Physician/exp OR Nurse 
practitioner/exp OR Pharmacist/exp OR Clinician/exp)
3. (Internet/exp OR Mobile application/exp OR 'Telehealth'/exp)
4. (1 AND 2) AND 3
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The basic search on Key terms via CINAHL will be:
1. (TI “Older adult*” OR AB “Older adult*” OR TI “Older person” OR AB “Older person” OR 
TI “Elderly” OR AB “Elderly” OR TI “Geriatric” OR AB “Geriatric”) AND (TI 
"Neoplasm*” OR AB "Neoplasm*” OR TI “Cancer” OR AB “Cancer” OR TI “Carcinoma” 
OR AB “Carcinoma”)
2. (TI “Famil*” OR AB “Famil*” OR TI “Health care provider*” OR AB “Health care 
provider*” OR TI “Healthcare professional*” OR AB “Healthcare professional*” OR TI 
“Carer*” OR AB “Carer*” OR TI “Caregiver*” OR AB “Caregiver*” OR TI “Nurs*” OR AB 
“Nurs*” OR TI “Oncolog*” OR AB “Oncolog*” OR TI “General practitioner” OR AB 
“General practitioner” OR TI “Practitioner” OR AB “Practitioner” OR TI “Nurse 
practitioner” OR AB “Nurse practitioner” OR TI “Pharmacy” OR AB “Pharmacy” OR TI 
“Clinician” OR AB “Clinician” OR TI “Physician” OR AB “Physician”)
3. (TI “Internet” OR AB “Internet” OR TI “Telemonitor*” OR AB “Telemonitor*” OR TI 
“Teleconsultat*” OR AB “Teleconsultat*” OR TI “Telehealth” OR AB “Telehealth” OR TI 
“Telecare” OR AB “Telecare” OR TI “Website*” OR AB “Website*” OR TI “App” OR AB 
“App” OR TI “Apps” OR AB “Apps” OR TI “Application*” OR AB “Application*” OR TI 
“Digital” OR AB “Digital” OR TI “eHealth” OR AB “eHealth” OR TI “mHealth” OR AB 
“mHealth”)
4. (1 AND 2) AND 3
The basic search on Exact Subject heading terms via CINAHL will be:
1. (MH "Aged+") AND (MH "Neoplasm Staging" OR MH "Cancer Patients" OR MH 
"Carcinoma")
2. (MH "Family" OR MH "Caregiver Support" OR MH "Health Personnel" OR MH "Nurses" OR  
MH "Oncologic care" OR MH "Physicians" OR MH "Nurse Practitioners")
3. (MH "Internet" OR MH "Mobile Applications" OR MH "Home Health Care Information 
Systems" OR MH "Health Information Networks") 
4. (1 AND 2) AND 3
The basic search on Key terms via SCOPUS will be:
1. TITLE-ABS-KEY ( older  AND adult*  OR  older  AND person  OR  elderly  OR Geriatric)  
AND TITLE-ABS-KEY (Neoplasm* OR Cancer OR Carcinoma)
2. TITLE-ABS-KEY (Famil* OR Health care provider* OR Healthcare professional* OR 
Carer* OR Caregiver* OR Nurs* OR Oncolog* OR General practitioner OR Practitioner OR 
Nurse practitioner OR Pharmacy OR Clinician OR Physician
3. TITLE-ABS-KEY (Internet OR Telemonitor* OR Teleconsultat* OR Telehealth OR Telecare 
OR Website* OR App OR Apps OR Application* OR Digital OR eHealth OR mHealth)
4. (1 AND 2) AND 3
The basic search on Key terms via PsycInfo will be:
1. (older adult* or older person or elderly or geriatric).mp. [mp=title, abstract, heading word, 
table of contents, key concepts, original title, tests & measures, mesh] AND (Neoplasm* or 
Cancer or Carcinoma).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures, mesh] 
2. (Famil* or Health care provider* or Healthcare professional* or Carer* or Cargiver* or Nurs* 
or Oncolog* or General practitioner or Practitioner or Nurse practitioner or Pharmacy or 
Clinician or Physician).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures, mesh] 
3. (internet or telemonitor* or teleconsultat* or telehealth or telecare or Website* or App or Apps 
or Application* or Digital or eHealth or mHealth).mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures, mesh]
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4. (1 AND 2) AND 3
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Preliminary Searches Results
Databases (1 AND 2) AND 3
Key 
terms
(Older adult*[Title/Abstract] OR Older person[Title/Abstract] OR 
Elderly[Title/Abstract] OR Geriatric[Title/Abstract]) AND 
(Neoplasm*[Title/Abstract] OR Cancer[Title/Abstract] OR 
Carcinoma[Title/Abstract]) AND (Famil*[Title/Abstract] OR Health care 
provider*[Title/Abstract] OR Healthcare professional*[Title/Abstract] OR 
Carer*[Title/Abstract] OR Caregiver*[Title/Abstract] OR 
Oncolog*[Title/Abstract] OR Nurs*[Title/Abstract] OR General 
practitioner[Title/Abstract] OR Practitioner[Title/Abstract] OR Nurse 
practitioner[Title/Abstract] OR Pharmacy[Title/Abstract] OR 
Clinician[Title/Abstract] OR Physician[Title/Abstract]) AND 
(Internet[Title/Abstract] OR Telemonitor*[Title/Abstract] OR 
Teleconsultat*[Title/Abstract] OR Telehealth[Title/Abstract] OR 
Telecare[Title/Abstract] OR Website*[Title/Abstract] OR 
App[Title/Abstract] OR Apps[Title/Abstract] OR 
Application*[Title/Abstract] OR Digital[Title/Abstract] OR 
eHealth[Title/Abstract] OR mHealth[Title/Abstract])
MeSH 
terms
(Aged[Mesh]) AND (Neoplasms[Mesh] OR Carcinoma[Mesh]) AND 
(Family[Mesh] OR Caregivers[Mesh] OR Health Personnel[Mesh] OR 
Nursing[Mesh] OR Nurses [Mesh] OR Oncology nursing[Mesh] OR 
General practitioners[Mesh] OR Nurse practitioners[Mesh] OR Family 
Nurse Practitioners[Mesh] OR Pharmacy[Mesh] OR Physicians[Mesh]) 
AND (Telemedicine[Mesh] OR Telecommunications[Mesh] OR Patient 
portals[Mesh] OR Mobile applications[Mesh] OR Internet-based 
intervention[Mesh])
Pubmed
Final (Older adult*[Title/Abstract] OR Older person[Title/Abstract] OR 
Elderly[Title/Abstract] OR Geriatric[Title/Abstract] OR Aged[Mesh]) 
AND (Neoplasm*[Title/Abstract] OR Cancer[Title/Abstract] OR 
Carcinoma[Title/Abstract] OR Neoplasms[Mesh] OR Carcinoma[Mesh]) 
AND (Famil*[Title/Abstract] OR Health care provider*[Title/Abstract] OR 
Healthcare professional*[Title/Abstract] OR Carer*[Title/Abstract] OR 
Caregiver*[Title/Abstract] OR Oncolog*[Title/Abstract] OR 
Nurs*[Title/Abstract] OR General practitioner[Title/Abstract] OR 
Practitioner[Title/Abstract] OR Nurse practitioner[Title/Abstract] OR 
Pharmacy[Title/Abstract] OR Clinician[Title/Abstract] OR 
Physician[Title/Abstract] OR Nursing[Mesh] OR Nurses [Mesh] OR 
Oncology nursing[Mesh] OR General practitioners[Mesh] OR Nurse 
practitioners[Mesh] OR Family Nurse Practitioners[Mesh] OR 
Pharmacy[Mesh] OR Physicians[Mesh]) AND (Internet[Title/Abstract] OR 
Telemonitor*[Title/Abstract] OR Teleconsultat*[Title/Abstract] OR 
Telehealth[Title/Abstract] OR Telecare[Title/Abstract] OR 
Website*[Title/Abstract] OR App[Title/Abstract] OR Apps[Title/Abstract] 
OR Application*[Title/Abstract] OR Digital[Title/Abstract] OR 
eHealth[Title/Abstract] OR mHealth[Title/Abstract] OR 
Telemedicine[Mesh] OR Telecommunications[Mesh] OR Patient 
portals[Mesh] OR Mobile applications[Mesh] OR Internet-based 
intervention[Mesh])
Cochrane Key 
terms
(Older adult*[Title/Abstract] OR Older person[Title/Abstract] OR 
Elderly[Title/Abstract] OR Geriatric[Title/Abstract]) AND 
(Neoplasm*[Title/Abstract] OR Cancer[Title/Abstract] OR 
Carcinoma[Title/Abstract]) AND (Famil*[Title/Abstract] OR Health care 
provider*[Title/Abstract] OR Healthcare professional*[Title/Abstract] OR 
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Carer*[Title/Abstract] OR Caregiver*[Title/Abstract] OR 
Oncolog*[Title/Abstract] OR Nurs*[Title/Abstract] OR General 
practitioner[Title/Abstract] OR Practitioner[Title/Abstract] OR Nurse 
practitioner[Title/Abstract] OR Pharmacy[Title/Abstract] OR 
Clinician[Title/Abstract] OR Physician[Title/Abstract]) AND 
(Internet[Title/Abstract] OR Telemonitor*[Title/Abstract] OR 
Teleconsultat*[Title/Abstract] OR Telehealth[Title/Abstract] OR 
Telecare[Title/Abstract] OR Website*[Title/Abstract] OR 
App[Title/Abstract] OR Apps[Title/Abstract] OR 
Application*[Title/Abstract] OR Digital[Title/Abstract] OR 
eHealth[Title/Abstract] OR mHealth[Title/Abstract])
MeSH 
terms
(Aged[Mesh]) AND (Neoplasms[Mesh] OR Carcinoma[Mesh]) AND 
(Family[Mesh] OR Caregivers[Mesh] OR Health Personnel[Mesh] OR 
Nursing[Mesh] OR Nurses [Mesh] OR Oncology nursing[Mesh] OR 
General practitioners[Mesh] OR Nurse practitioners[Mesh] OR Family 
Nurse Practitioners[Mesh] OR Pharmacy[Mesh] OR Physicians[Mesh]) 
AND (Telemedicine[Mesh] OR Telecommunications[Mesh] OR Patient 
portals[Mesh] OR Mobile applications[Mesh] OR Internet-based 
intervention[Mesh])
Final (Older adult*[Title/Abstract] OR Older person[Title/Abstract] OR 
Elderly[Title/Abstract] OR Geriatric[Title/Abstract] OR Aged[Mesh]) 
AND (Neoplasm*[Title/Abstract] OR Cancer[Title/Abstract] OR 
Carcinoma[Title/Abstract] OR Neoplasms[Mesh] OR Carcinoma[Mesh]) 
AND (Famil*[Title/Abstract] OR Health care provider*[Title/Abstract] OR 
Healthcare professional*[Title/Abstract] OR Carer*[Title/Abstract] OR 
Caregiver*[Title/Abstract] OR Oncolog*[Title/Abstract] OR 
Nurs*[Title/Abstract] OR General practitioner[Title/Abstract] OR 
Practitioner[Title/Abstract] OR Nurse practitioner[Title/Abstract] OR 
Pharmacy[Title/Abstract] OR Clinician[Title/Abstract] OR 
Physician[Title/Abstract] OR Nursing[Mesh] OR Nurses [Mesh] OR 
Oncology nursing[Mesh] OR General practitioners[Mesh] OR Nurse 
practitioners[Mesh] OR Family Nurse Practitioners[Mesh] OR 
Pharmacy[Mesh] OR Physicians[Mesh]) AND (Internet[Title/Abstract] OR 
Telemonitor*[Title/Abstract] OR Teleconsultat*[Title/Abstract] OR 
Telehealth[Title/Abstract] OR Telecare[Title/Abstract] OR 
Website*[Title/Abstract] OR App[Title/Abstract] OR Apps[Title/Abstract] 
OR Application*[Title/Abstract] OR Digital[Title/Abstract] OR 
eHealth[Title/Abstract] OR mHealth[Title/Abstract]) OR 
Telemedicine[Mesh] OR Telecommunications[Mesh] OR Patient 
portals[Mesh] OR Mobile applications[Mesh] OR Internet-based 
intervention[Mesh])
Key 
terms
(Older adult*:ti,ab OR Older person:ti,ab OR Elderly:ti,ab OR 
Geriatric:ti,ab) AND  (Neoplasm*:ti,ab OR Cancer:ti,ab OR 
Carcinoma:ti,ab) AND (Famil*:ti,ab OR Health care provider*:ti,ab OR 
Healthcare professional*:ti,ab OR Carer*:ti,ab OR Caregiver*:ti,ab OR 
Nurs*:ti,ab OR Oncolog*:ti,ab OR General practitioner:ti,ab OR 
Practitioner:ti,ab OR Nurse practitioner:ti,ab OR Pharmacy:ti,ab OR 
Clinician:ti,ab OR Physician:ti,ab) AND (Internet:ti,ab OR 
Telemonitor*:ti,ab OR Teleconsultat*:ti,ab OR Telehealth:ti,ab OR 
Telecare:ti,ab OR Website*:ti,ab OR App:ti,ab OR Apps:ti,ab OR 
application*:ti,ab OR Digital/exp OR 'eHeallth'/exp OR 'mHealth'/exp)
EMBASE
Emtree 
terms
(Aged/exp OR Geriatric patient/exp) AND (Neoplasm/exp OR Cancer/exp 
OR Carcinoma/exp) AND (Family/exp OR Health care personnel/exp OR 
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Health Personnel/exp OR Nursing/exp OR Oncology/exp OR Nursing/exp 
OR General practitioner/exp OR Physician/exp OR Nurse practitioner/exp 
OR Pharmacist/exp OR Clinician/exp) AND (Internet/exp OR Mobile 
application/exp OR 'Telehealth'/exp)
Final (('older adult*':ab,ti OR 'older person':ab,ti OR elderly:ab,ti OR 
geriatric:ab,ti OR 'aged'/exp OR 'geriatric patient'/exp) AND 
(neoplasm*:ab,ti OR cancer:ab,ti OR carcinoma:ab,ti) OR 'neoplasm'/exp 
OR 'cancer'/exp OR 'carcinoma'/exp) AND (((famil*:ab,ti OR health:ab,ti) 
AND care:ab,ti AND provider*:ti,ab OR healthcare:ab,ti) AND 
professional*:ti,ab OR carer*:ti,ab OR caregiver*:ti,ab OR nurs*:ti,ab OR 
oncolog*:ab,ti OR 'general practitioner':ab,ti OR practitioner:ab,ti OR 
'nurse practitioner':ab,ti OR pharmacy:ab,ti OR clinician:ab,ti OR 
physician:ab,ti) AND ('family'/exp OR 'health care personnel'/exp OR 
'health personnel'/exp OR 'oncology'/exp OR 'nursing'/exp OR 'general 
practitioner'/exp OR 'physician'/exp OR 'nurse practitioner'/exp OR 
'pharmacist'/exp OR 'clinician'/exp) AND (internet:ab,ti OR 
telemonitor*:ab,ti OR teleconsultat*:ab,ti OR telehealth:ab,ti OR 
telecare:ab,ti OR website*:ab,ti OR app:ab,ti OR apps:ab,ti OR 
application*:ab,ti OR digital:ab,ti OR eheallth:ab,ti OR mhealth:ab,ti) 
AND ('internet'/exp OR 'mobile application'/exp OR 'telehealth'/exp)
Key 
terms
(TI “Older adult*” OR AB “Older adult*” OR TI “Older person” OR AB 
“Older person” OR TI “Elderly” OR AB “Elderly” OR TI “Geriatric” OR 
AB “Geriatric”) AND (TI "Neoplasm*” OR AB "Neoplasm*” OR TI 
“Cancer” OR AB “Cancer” OR TI “Carcinoma” OR AB “Carcinoma”) 
AND (TI “Famil*” OR AB “Famil*” OR TI “Health care provider*” OR 
AB “Health care provider*” OR TI “Healthcare professional*” OR AB 
“Healthcare professional*” OR TI “Carer*” OR AB “Carer*” OR TI 
“Caregiver*” OR AB “Caregiver*” OR TI “Nurs*” OR AB “Nurs*” OR TI 
“Oncolog*” OR AB “Oncolog*” OR TI “General practitioner” OR AB 
“General practitioner” OR TI “Practitioner” OR AB “Practitioner” OR TI 
“Nurse practitioner” OR AB “Nurse practitioner” OR TI “Pharmacy” OR 
AB “Pharmacy” OR TI “Clinician” OR AB “Clinician” OR TI “Physician” 
OR AB “Physician”) AND (TI “Internet” OR AB “Internet” OR TI 
“Telemonitor*” OR AB “Telemonitor*” OR TI “Teleconsultat*” OR AB 
“Teleconsultat*” OR TI “Telehealth” OR AB “Telehealth” OR TI 
“Telecare” OR AB “Telecare” OR TI “Website*” OR AB “Website*” OR 
TI “App” OR AB “App” OR TI “Apps” OR AB “Apps” OR TI 
“Application*” OR AB “Application*” OR TI “Digital” OR AB “Digital” 
OR TI “eHealth” OR AB “eHealth” OR TI “mHealth” OR AB “mHealth”)
Exact 
Subject 
heading 
terms
(MH "Aged+") AND (MH "Neoplasm Staging" OR MH "Cancer Patients" 
OR MH "Carcinoma") AND (MH "Family" OR MH "Caregiver Support" 
OR MH "Health Personnel" OR MH "Nurses" OR  MH "Oncologic care" 
OR MH "Physicians" OR MH "Nurse Practitioners") AND (MH "Internet" 
OR MH "Mobile Applications" OR MH "Home Health Care Information 
Systems" OR MH "Health Information Networks") 
CINAHL
Final TI ( Older adult* OR Older person OR Elderly OR Geriatric ) OR AB 
( Older adult* OR Older person OR Elderly OR Geriatric ) OR MH Aged+  
AND TI ( Neoplasm OR Cancer OR Carcinoma ) OR AB ( Neoplasm OR 
Cancer OR Carcinoma ) OR MH ( Neoplasm Staging OR Cancer Patients 
OR Carcinoma ) AND TI ( Famil* OR Health care provider* OR 
Healthcare professional* OR Carer* OR Caregiver* OR Nurs* OR 
Oncolog* OR General practitioner OR Practitioner OR Nurse practitioner 
OR Pharmacy OR Clinician OR Physician ) OR AB ( Famil* OR Health 
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care provider* OR Healthcare professional* OR Carer* OR Caregiver* OR 
Nurs* OR Oncolog* OR General practitioner OR Practitioner OR Nurse 
practitioner OR Pharmacy OR Clinician OR Physician ) OR MH ( Family 
OR Caregiver Support OR Health Personnel OR Nurses OR Oncologic care 
OR Physicians OR Nurse Practitioners ) AND TI ( Internet OR 
Telemonitor* OR Teleconsultat* OR Telehealth OR Telecare OR Website* 
OR App OR Apps OR Application*OR Digital OR eHealth OR mHealth ) 
OR AB ( Internet OR Telemonitor* OR Teleconsultat* OR Telehealth OR 
Telecare OR Website* OR App OR Apps OR Application*OR Digital OR 
eHealth OR mHealth ) OR MH ( Internet OR Mobile Application OR 
Home Health Care Information Systems OR Health Information 
Networks )  
SCOPUS Key 
terms 
and Final
( TITLE-ABS-KEY ( older  AND adult*  OR  older  AND person  OR  
elderly  OR  geriatric ) )  AND  ( ( ( neoplasm*  OR  cancer  OR  
carcinoma ) )  AND  ( famil*  OR  health  AND care  AND provider*  OR  
healthcare  AND professional*  OR  carer*  OR  caregiver*  OR  nurs*  
OR  oncolog*  OR  general  AND practitioner  OR  practitioner  OR  nurse  
AND practitioner  OR  pharmacy  OR  clinician  OR  physician ) )  AND  
( internet  OR  telemonitor*  OR  teleconsultat*  OR  telehealth  OR  
telecare  OR  website*  OR  app  OR  apps  OR  application*  OR  digital  
OR  ehealth  OR  mhealth )  
PsycInfo Key 
terms 
and Final
(older adult* or older person or elderly or geriatric).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & 
measures, mesh] AND (Neoplasm* or Cancer or Carcinoma).mp. 
[mp=title, abstract, h ading word, table of contents, key concepts, original 
title, tests & measures, mesh] AND (Famil* or Health care provider* or 
Healthcare professional* or Carer* or Cargiver* or Nurs* or Oncolog* or 
General practitioner or Practitioner or Nurse practitioner or Pharmacy or 
Clinician or Physician).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures, mesh] AND 
(internet or telemonitor* or teleconsultat* or telehealth or telecare or 
Website* or App or Apps or Application* or Digital or eHealth or 
mHealth).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures, mesh]
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